93 related articles for article (PubMed ID: 1180426)
1. Reduced systemic vascular resistance as therapy for severe mitral regurgitation of valvular origin.
Harshaw CW; Grossman W; Munro AB; McLaurin LP
Ann Intern Med; 1975 Sep; 83(3):312-6. PubMed ID: 1180426
[TBL] [Abstract][Full Text] [Related]
2. Afterload reduction therapy with nitroprusside in severe aortic regurgitation: improved cardiac performance and reduced regurgitant volume.
Miller RR; Vismara LA; DeMaria AN; Salel AF; Mason DT
Am J Cardiol; 1976 Nov; 38(5):564-7. PubMed ID: 983953
[TBL] [Abstract][Full Text] [Related]
3. Comparison of intraoperative nitroprusside unloading in mitral and aortic regurgitation.
Stone JG; Hoar PF; Faltas AN; Johnson LL; Edie RN; Bowman FO; Malm JR
J Thorac Cardiovasc Surg; 1979 Jul; 78(1):103-9. PubMed ID: 449373
[TBL] [Abstract][Full Text] [Related]
4. Effect of the vasodilator therapy in regurgitant valvular disease.
Sasayama S; Ohyagi A; Lee JD; Nonogi H; Sakurai T; Wakabayashi A; Fujita M; Kawai C
Jpn Circ J; 1982 Apr; 46(4):433-41. PubMed ID: 7087161
[TBL] [Abstract][Full Text] [Related]
5. Afterload reduction with vasodilators and diuretics decreases mitral regurgitation during upright exercise in advanced heart failure.
Stevenson LW; Brunken RC; Belil D; Grover-McKay M; Schwaiger M; Schelbert HR; Tillisch JH
J Am Coll Cardiol; 1990 Jan; 15(1):174-80. PubMed ID: 2295730
[TBL] [Abstract][Full Text] [Related]
6. Beneficial effects of hydralazine in severe mitral regurgitation.
Greenberg BH; Massie BM; Brundage BH; Botvinick EH; Parmley WW; Chatterjee K
Circulation; 1978 Aug; 58(2):273-9. PubMed ID: 668075
[TBL] [Abstract][Full Text] [Related]
7. Effect of nitroprusside on left ventricular dynamics in mitral regurgitation.
Goodman DJ; Rossen RM; Holloway EL; Alderman EL; Harrison DC
Circulation; 1974 Nov; 50(5):1025-32. PubMed ID: 4430088
[No Abstract] [Full Text] [Related]
8. Contribution of reduced mitral regurgitant volume to vasodilator effect in severe left ventricular failure secondary to coronary artery disease or idiopathic dilated cardiomyopathy.
Weiland DS; Konstam MA; Salem DN; Martin TT; Cohen SR; Zile MR; Das D
Am J Cardiol; 1986 Nov; 58(10):1046-50. PubMed ID: 3776843
[TBL] [Abstract][Full Text] [Related]
9. [The relationships between left ventricular volumes and ejection fraction in mitral and aortic regurgitation (author's transl)].
Strauer BE; Kramer H; Bolte H; Riecker G
Klin Wochenschr; 1975 Oct; 53(20):795-84. PubMed ID: 1202276
[TBL] [Abstract][Full Text] [Related]
10. Acute hemodynamic effects of nitroprusside in children with isolated mitral regurgitation.
Nakano H; Ueda K; Saito A
Am J Cardiol; 1985 Aug; 56(4):351-5. PubMed ID: 4025177
[TBL] [Abstract][Full Text] [Related]
11. Hemodynamic consequences of afterload reduction in patients with chronic aortic regurgitation.
Bolen JL; Alderman EL
Circulation; 1976 May; 53(5):879-83. PubMed ID: 1260993
[TBL] [Abstract][Full Text] [Related]
12. Effects of nitroprusside-induced reduction of elevated preload and afterload on global and regional ventricular function in acute myocardial infarction.
Shah PK; Abdulla A; Pichler M; Shellock F; Berman D; Singh BN; Swan HJ
Am Heart J; 1983 Apr; 105(4):531-42. PubMed ID: 6837407
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of nitroprusside therapy in postcardiotomy low-output syndrome necessitating intra-aortic balloon counterpulsation.
Sturm JT; Fuhrman TM; Igo SR; Norman JC
J Thorac Cardiovasc Surg; 1979 Aug; 78(2):254-8. PubMed ID: 459533
[TBL] [Abstract][Full Text] [Related]
14. Pilot study to assess the influence of beta-blockade on mitral regurgitant volume and left ventricular work in degenerative mitral valve disease.
Stewart RA; Raffel OC; Kerr AJ; Gabriel R; Zeng I; Young AA; Cowan BR
Circulation; 2008 Sep; 118(10):1041-6. PubMed ID: 18725484
[TBL] [Abstract][Full Text] [Related]
15. Digitalis-induced increase in aortic regurgitation and the contrasting effect of glucagon in the sedated dog.
Hopkins BE; Taylor RR
J Clin Invest; 1974 Jun; 53(6):1716-25. PubMed ID: 4830233
[TBL] [Abstract][Full Text] [Related]
16. Early Hemodynamic Improvement after Percutaneous Mitral Valve Repair Evaluated by Noninvasive Pressure-Volume Analysis.
Lavall D; Reil JC; Segura Schmitz L; Mehrer M; Schirmer SH; Böhm M; Laufs U
J Am Soc Echocardiogr; 2016 Sep; 29(9):888-98. PubMed ID: 27372560
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of reduction of mitral regurgitation with vasodilator therapy.
Yoran C; Yellin EL; Becker RM; Gabbay S; Frater RW; Sonnenblick EH
Am J Cardiol; 1979 Apr; 43(4):773-7. PubMed ID: 425914
[TBL] [Abstract][Full Text] [Related]
18. Systemic and pulmonary effects of nitroprusside during mitral valve replacement in patients with mitral regurgitation.
Lappas DG; Ohtaka M; Fahmy NR; Buckley MJ
Circulation; 1978 Sep; 58(3 Pt 2):I18-22. PubMed ID: 14740671
[TBL] [Abstract][Full Text] [Related]
19. Effects of afterload reduction (diuretics and vasodilators) on left ventricular volume and mitral regurgitation in severe congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
Stevenson LW; Bellil D; Grover-McKay M; Brunken RC; Schwaiger M; Tillisch JH; Schelbert HR
Am J Cardiol; 1987 Sep; 60(8):654-8. PubMed ID: 3661430
[TBL] [Abstract][Full Text] [Related]
20. Acute haemodynamic effects of oral prazosin in severe mitral regurgitation.
Mehta J; Feldman RL; Nichols WW; Pepine CJ; Conti CR
Br Heart J; 1980 May; 43(5):556-60. PubMed ID: 7378216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
